- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.11. | BIOTRICITY INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | Biotricity GAAP EPS of -$0.03, revenue of $3.9M in-line | 1 | Seeking Alpha | ||
| 14.11. | Biotricity reports 19% revenue growth in Q2 fiscal 2026 | 1 | Investing.com | ||
| 14.11. | Biotricity Inc.: Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026 | 172 | GlobeNewswire (Europe) | REDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape... ► Artikel lesen | |
| BIOTRICITY Aktie jetzt für 0€ handeln | |||||
| 14.11. | BIOTRICITY INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | Biotricity Inc.: Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th | 1 | GlobeNewswire (USA) | ||
| 03.09. | Biotricity Inc.: Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform | 1 | GlobeNewswire (USA) | ||
| 14.08. | Biotricity erreicht Meilenstein: Erstmals positives EBITDA im ersten Quartal 2026 | 2 | Investing.com Deutsch | ||
| 14.08. | Biotricity Inc.: Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins | 284 | GlobeNewswire (Europe) | REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape... ► Artikel lesen | |
| 14.08. | BIOTRICITY INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 12.08. | Biotricity Inc.: Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th | 2 | GlobeNewswire (USA) | ||
| 22.07. | H.C. Wainwright maintains Neutral rating on Biotricity stock despite growth | 1 | Investing.com | ||
| 17.07. | Biotricity reports Q4 results | 2 | Seeking Alpha | ||
| 17.07. | Biotricity Inc.: Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach | 164 | GlobeNewswire (Europe) | FY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses... ► Artikel lesen | |
| 15.07. | BIOTRICITY INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 15.07. | Biotricity Inc.: Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th | 1 | GlobeNewswire (USA) | ||
| 01.07. | BIOTRICITY INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 20.02. | Biotricity Inc.: Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025 | 199 | GlobeNewswire (Europe) | Company reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying... ► Artikel lesen | |
| 17.02. | Biotricity Inc.: Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11% | 217 | GlobeNewswire (Europe) | Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million - an 11% increase sequentially from the immediately preceding quarterManagement continues... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALPHATEC | 17,960 | +0,28 % | Morning Market Movers: SPS Commerce, Brighthouse Financial, Alphatec, Ardelyx See Big Swings | SEATTLE (dpa-AFX) - At 7:45 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,530 | +0,83 % | DAX bald auf 6-Monats-Tief - BMW, RTL, SAP, Scout, SFC Energy und Siemens Healthineers im ... | Die Sorge über eine weniger lockere Geldpolitik der US-Notenbank hat zum Wochenstart die internationalen Aktienmärkte - darunter auch den DAX - auf Talfahrt geschickt. Die Tendenz setzt sich zum Handelsstart... ► Artikel lesen | |
| FRESENIUS | 47,660 | +0,97 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,670 | +0,65 % | FMC, Lanxess, Norma, Redcare Pharmacy, Suss MicroTec, TKMS - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,105 | +8,43 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CARL ZEISS MEDITEC | 46,100 | +2,44 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hatCarl Zeiss Meditec auf "Overweight" mit einem Kursziel von 52 Euro belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,260 | +7,50 % | Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) | ||
| BRIGHTSPRING HEALTH SERVICES | 36,200 | +2,87 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 167,46 | +3,91 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| GERRESHEIMER | 24,860 | +2,39 % | EQS-News: Gerresheimer AG: Science Based Targets Initiative bestätigt CO2e Reduktionsziele | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer: Science Based Targets Initiative bestätigt CO2e Reduktionsziele
18.11.2025 / 10:02 CET/CEST
Für... ► Artikel lesen | |
| PROGYNY | 26,810 | +1,82 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| PACS GROUP | 32,000 | +6,70 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NUTEX HEALTH | 120,05 | -12,42 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen | |
| BILLIONTOONE | 128,80 | +7,21 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | -1,88 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber |
Das Unternehmen BIOTRICITY INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOTRICITY INC finden Sie auf Wallstreet Online.